跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 110,213 条关于
“HER2 positive breast cancer”
全部
110,213
临床试验
85,873
药物
2,618
机构
1,178
资讯
20,544
去年
Repurposed Cancer Drug Shows Promise in Treating HER2-Positive Breast Cancer
2年前
Trastuzumab Deruxtecan Shows Efficacy in HER2-Positive Breast Cancer Brain Metastases
4个月前
Russia's Biocad Initiates Phase III Trial of Kadcyla Biosimilar BCD-237 for HER2-Positive Breast Cancer
去年
Trastuzumab Duocarmazine Demonstrates Efficacy in HER2-Positive Metastatic Breast Cancer
11个月前
Pfizer's Tukysa Shows Positive Results in Phase III Maintenance Trial for HER2-Positive Breast Cancer
2年前
Personalized, Less Toxic Therapies Advance Treatment for HER2-Positive Breast Cancer
去年
Er-Kim and Puma Biotechnology Partner to Bring NERLYNX to Eastern Europe and Central Asia for HER2-Positive Breast Cancer Patients
去年
Enhertu Demonstrates Significant Overall Survival Benefit in HER2-Positive Breast Cancer Phase III Trial
去年
Ten-Year APHINITY Data Shows Perjeta-Based Regimen Reduces Death Risk by 17% in HER2-Positive Early Breast Cancer
11天前
Biocon Secures 10-Year Brazil Supply Contract for Pertuzumab in HER2-Positive Breast Cancer
第 1 页，共 2055 页
上一页
下一页
